Please ensure Javascript is enabled for purposes of website accessibility
network member

Parkview Research Center

Fort Wayne, IN
Parkview Research Center

About Network Member

Currently Enrolling

HCRN-GI23-617

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors.
Cancer areas:Small Bowel
Atlantic Health System
Moffitt Cancer Center
Parkview Research Center
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
University of Illinois Cancer Center
UT Southwestern Harold C. Simmons Comprehensive Cancer Center
Virginia Commonwealth University
Currently Enrolling

HCRN-BRE20-468

A Phase II Study of Ribociclib And Endocrine Treatment of Physician’s Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer (RaPhLRR Study)
Cancer areas:Breast
Fred & Pamela Buffett Cancer Center
Georgetown Lombardi Comprehensive Cancer Center
Medical University of South Carolina
New York University Cancer Institute
Parkview Research Center
Penn State Cancer Institute
Providence Cancer Institute
Rutgers Cancer Institute
The Ohio State University
Tufts Medical Center
University of Alabama at Birmingham Comprehensive Cancer Center
University of Arizona Cancer Center
University of Illinois Cancer Center
University of Iowa Holden Comprehensive Cancer Center
University of Michigan Rogel Cancer Center
University of New Mexico Comprehensive Cancer Center
University of Virginia Cancer Center
University of Wisconsin Carbone Cancer Center
Virginia Commonwealth University